Congratualtions

著者：medicilon   アップロード：2020-06-04  閲読回数：

Congratualtions to Medicilon’s partner, Bio-Thera, on obtaining NMPA’s approval of clinical trials of BAT1308.

On May 27th, 2020, Bio-Thera Solutions, Ltd, annouced the approval of clinical trials on BAT 1308, an anti PD-1 monoclonal antibody. Medicilon participated in BAT 1308’s preclinical study by conducting the In Vivo PK test and safety evaluation tests under GLP.

上の：ノー上の

下に：Congratulations on the successful listing of Kintor Pharma